CellPhire Therapeutics
Operator of a clinical-stage biotechnology company intended to design long shelf-life platelet-derived therapeutics. The company's technology has applications that have potential applications in healt...
Valuation
$0
Share Price
N/A
Total Raised
$51.2M
Last Round
N/A